Driving Discovery with AI: Inside Novartis’ Approach

Birgit Schoeberl | Global Head of Data Science, Novartis

Explore the practical side of AI with insights from Novartis' VP for Translational Modeling & Simulation and Data Science. Learn about Novartis’ internal AI initiatives with real-world use cases, including applications across predictive safety and target identification. This talk offers a firsthand look into successful AI strategies, including specific efforts in early development and discovery at Novartis, equipping attendees with actionable insights for their AI implementation journey.

Unlocking the Genomic Odyssey: Inspiring our scientists to discover new targets

Eric Adam | Global Head of Operations, Neuroscience and Rare Diseases, Roche

Navigate the complex world of neurology with Eric Adams, the Global Head of Operations, Neuroscience, and Rare Diseases at Roche. In a field marked by immense scientific challenges and unique hurdles to target discovery, emerging consortia and seminal research are rewriting the landscape. 

Lessons from Takeda: Laying the foundations to accelerate the path from data to insight

Sean Liu | Head of Scientific Assets & Decision Support, Takeda

This talk will provide a view into Takeda's blueprint for developing a connected, end-to-end data platform designed to transform information into knowledge. Learn how they are advancing the development of a global data and analytics platform, with a specific application in better lead identification and optimization. Explore their efforts in overcoming data silos, enabling streamlined access and insights into diverse datasets, and fostering efficient communication within the organization. 

Uncharted Waters: Navigating the evolving policy landscape of AI in Healthcare

Christina Silcox | Research Director for Digital Health, Duke-Margolis Center

As AI and digital health technologies evolve at unprecedented pace, navigating changes in the policy landscape is also crucial. In her talk, Christina will delve into the latest policy developments, initiatives and frameworks laid out by various U.S. and global agencies, including the FDA, focusing on the use of AI in health and medical product development.

From Discovery to Triage: Improving the target selection process with multi-modal data

Kevin Munnelly | SVP, Platform technologies, Third Rock Ventures

Gain insights into the use of multi-modal data for robust target identification and triage spanning genetics, disease, molecular and cellular biology, disease models, pharmacology, and clinical aspects. Learn about the advanced methodologies and technologies employed for improving the target selection process, including the integration of tools like Causaly for enhanced mechanistic evidence.

Deploying AI into the Enterprise

Bob van Luijt | Co-founder & CEO, Weviate

Gain insights into the use of multi-modal data for robust target identification and triage spanning genetics, disease, molecular and cellular biology, disease models, pharmacology, and clinical aspects. Learn about the advanced methodologies and technologies employed for improving the target selection process, including the integration of tools like Causaly for enhanced mechanistic evidence.

[Fireside chat] AI and the Enterprise: Imagining the possibilities and debunking the myths

Anantha Kancherla | Engineer, Meta

Artur Saudabayev | CTO and Co-Founder, Causaly

In this fireside chat between Anantha Kancherla, the Former Head of AI Platform at Meta, and Artur Saudabayev, CTO & Co-founder of Causaly, get a balanced, forward-thinking perspective on AI-enabled enterprise transformation. Anantha and Artur will disentangle expectations from reality,  while offering their point of view on how the technology is poised to evolve and how organizations should prepare.

[Panel Discussion] Traversing the AI Frontier

Birgit Schoeberl | Global Head of Data Science, Novartis    

Eric Adam | Global Head of Operations, Neuroscience and Rare Diseases, Roche

Justin H. Johnson | Executive Director, Oncology Data Science, AstraZeneca

Caroline Xie | General Partner at ICONIQ Growth

Join R&D leaders from Novartis, Roche and Astra Zeneca for an illuminating panel discussion as they share how their organizations are embracing new technology, specific scientific and organizational hurdles they have encountered, and their unique perspectives and vision for the future. Engage in the conversation, explore diverse viewpoints, and garner key insights to inform and enhance your own organizational strategies and approaches.